|
|
|
|
$21m to be injected in the bioeconomy
The American biotech community is enthralled by the Obama Administration announcement of an important release of funds to be invested in the development of biobased products, education and training. “Today’s investment […] will have a direct impact on local economies now and set us up for a brighter, more innovative future”, said Agriculture Secretary, Tom Vilsack. A superb show of trust towards the bioeconomy. Read more
No revision of the EU Biotech Patents Directive in sight
At a symposium organised by the Dutch Presidency on 18 May, where EuropaBio was represented by the Chair of its IP Working Group, Dr Andreas Popp, both European Commissioner Elżbieta Bienkowska and Dutch Agricultural Minister Van Dam stated that the solutions to find a balance between the systems for patent and plant variety protection will not include an opening of the Biotech Patents Directive 98/44/EC. The European biotech sector strongly welcomed these announcements regarding one of Europe’s key innovation drivers. Our Intellectual Property factsheet focused on the issues discussed during the symposium gives you the opportunity to learn more about the role of patents in the agricultural biotech sector.
G7 pushing for Inclusive Innovation and Open Science
Through an official communique, the G7 Science and Technology Ministerial Meeting agreed on making every possible effort to put innovation at the center of social development. The meeting also announced a series of means to accelerate progress of the clean energy technologies in order to address climate change. Furthermore, attendees finalised an action plan for an easier access to science and more effective aging and elderly care.
|
|
|
Agricultural biotech
One more report to add to the growing stack of studies confirming that GMOs are as safe for human health as their non-GM counterparts. According to the Alliance for Science, the report has highlighted “the importance of amplifying farmers' voices and public sector investment” in the development of these emerging tools. Read more |
|
|
Healthcare biotech
In a recently released report, the European Medicines Agency considered in a report the year 2015 to have been a year of significant development in the scientific guidance provided to healthcare companies. The report also revealed how to ensure a better synergy between regulators and health-technology-assessment bodies on data requirements. Read more
|
|
|
Industrial biotech
The European Commission Vice-President for Jobs, Growth, Investment and Competitiveness Jyrki Katainen, recently underlined the concept of sustainable investment and the importance of financing environmental sustainability in a world with limited resources. Is he thinking beyond the current Commission’s green strategies? Read more
|
|
|
|
|
|
|
|
